Prescription Drug Freight Fraud Report, June 2025

What if your tirzepatide shipment came from a Brazilian beauty clinic? Or a vial of semaglutide was manufactured, supposedly, at a Costco in Toronto? In April and May 2025, dozens of shipments of semaglutide, tirzepatide, apixaban, and antibiotics entered the U.S. from facilities that aren’t in the FDA’s drug manufacturing database. These aren’t low-volume personal-use…

[...]

Handout: Illegal ingredients linked to knockoff weight loss drugs pouring in from foreign sources

Compounded versions of GLP-1 injectable treatments for diabetes and obesity have surged in popularity despite a lack the safety and efficacy assurances. The FDA has warned that these knockoff versions sometimes contain illicit semaglutide or tirzepatide—the active pharmaceutical ingredients (APIs) in weight loss drugs. Working with George Karavetsos, former director of FDA’s Office of Criminal…

[...]

July 29, 2020 video: Importation Executive Order Explainer

On July 24, 2020, the White House issued an executive order to implement three approaches to foreign drug importation, all of which involve dipping into other countries’ drug supplies and putting them in U.S. medicine cabinets. Watch this week’s video to learn more.

[...]